Back to Search
Start Over
Clinical Features and HSCT Outcome for SCID in Turkey
- Source :
- Journal of clinical immunology. 39(3)
- Publication Year :
- 2018
-
Abstract
- Elhan, Atilla Halil/0000-0003-3324-248X; Ikinciogullari, Aydan/0000-0003-1145-0843; Dogu, Figen/0000-0002-7869-4941; ates, can/0000-0003-2286-4398 WOS: 000468974100018 PubMed: 30924026 Severe combined immunodeficiency (SCID) is the most serious PID, characterized by T cell lymphopenia and lack of antigen-specific T cell and B cell immune responses, inevitably leading to death within the first year of life if hematopoietic stem cell transplantation (HSCT) is not performed. Purpose and Methods Since SCID is a common type of PID with an estimated incidence of 1/10.000 in Turkey, a retrospective analysis of HSCT characteristics, survival, immune recovery, and the major clinical features of SCID prior to HSCT is the aim of this multi-transplant center-based analysis. Results A total of 234 SCID patients transplanted between the years 1994 and 2014 were included in the study. Median age at diagnosis was 5 months, at transplantation, 7 months, B- phenotype and RAGs were the most common defects among others. Immune phenotype did not seem to have an effect on survival rate (p > 0.05), Immunoglobulin (Ig) requirement following HSCT did not differ between B+ and B- phenotypes (p > 0.05). Overall survival rate was 65.7% over a period of 20 years. It increased from 54% (1994-2004) to 69% (p = 0.052) during the last 10 years (2005-2014). Ten-year survival after HSCT has improved over time although the difference was not significant. Infection at the time of transplantation (p = 0.006), mismatched related donor (MMRD) (haploidentical parents), and matched unrelated donor (MUD) donor transplants p < 0.001 were the most important factors, significantly affecting the outcome. Conclusions This is the first multicenter study with the largest data obtained from transplanted SCID patients in Turkey. Early diagnosis with newborn screening (NBS) together with emerging referrals, treatment by transplantation centers, and specialized teams are mandatory in countries with high parental consanguinity such as Turkey.
- Subjects :
- 0301 basic medicine
Oncology
Male
medicine.medical_specialty
clinical features
Turkey
medicine.medical_treatment
T cell
Immunology
Graft vs Host Disease
Hematopoietic stem cell transplantation
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
Immune Tolerance
Immunology and Allergy
Medicine
Humans
Survival rate
Newborn screening
Severe combined immunodeficiency
B-Lymphocytes
biology
business.industry
Incidence (epidemiology)
Hematopoietic Stem Cell Transplantation
Infant
medicine.disease
Severe combined immune deficiency (SCID)
Survival Analysis
Transplantation
030104 developmental biology
medicine.anatomical_structure
surgical procedures, operative
Treatment Outcome
Histocompatibility
biology.protein
outcome
Hematopoietic stem cell transplantation (HSCT)
Female
Severe Combined Immunodeficiency
Antibody
business
030215 immunology
Subjects
Details
- ISSN :
- 15732592
- Volume :
- 39
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Journal of clinical immunology
- Accession number :
- edsair.doi.dedup.....945f5aab2e2ec55937401736e71cde39